Using knotless implants for hip capsule closure during surgery
Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
This study tests if a new knotless device for closing the hip capsule during surgery can help patients recover better than traditional knotted sutures.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | American Hip Institute Academic / other |
| Locations | 1 site (Des Plaines, Illinois) |
| Trial ID | NCT06500364 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the Arthrex LoopLocTM device for closing the hip capsule during primary hip arthroscopy compared to traditional knotted sutures. The hip capsule, which stabilizes the hip joint, is cut during surgery and needs to be repaired afterward. The LoopLocTM device is designed to minimize irritation and scar tissue formation, potentially leading to improved patient outcomes. Participants will be monitored for two years to assess their recovery and overall results from the surgery.
Who should consider this trial
Good fit: Ideal candidates are patients under 60 years old who are scheduled for primary hip arthroscopy and will receive capsular closure with the LoopLocTM device.
Not a fit: Patients who have had previous hip surgery or significant cartilage damage may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to reduced pain and better recovery outcomes for patients undergoing hip arthroscopy.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in improving surgical outcomes with alternative closure techniques.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing a primary hip arthroscopy * Patients younger than 60 years old. * Patients who will receive capsular closure with the Arthrex LoopLocTM device following hip arthroscopy. Exclusion Criteria: * Patients that had previous hip surgery, * Patients that had a center edge angle (CEA) less than 25 degrees or greater than 40 degrees. * Patients that have a cartilage damage grade greater than or equal to 3.
Where this trial is running
Des Plaines, Illinois
- American Hip Institute Research Foundation — Des Plaines, Illinois, United States (Recruiting)
Study contacts
- Study coordinator: Alexandra Mantice
- Email: alexandra.mantice@americanhipinstitute.org
- Phone: 8338724477
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.